scorecardresearch
Add as a preferred source on Google
Sunday, April 19, 2026
TopicWeight loss drug

Topic: weight loss drug

Mounjaro or Ozempic? What 1st study on Indian cohort found out about efficacy of anti-obesity drugs

Published in Indian Journal of Endocrinology and Metabolism, the study finds that patients without diabetes lost more than double the weight compared to those with the condition.

Genes decide who responds better to GLP-1 drugs. How Nature study findings can change obesity treatment

The study finds specific genetic variants that predict how much weight a person will lose on taking weight loss drugs, & the severity of side effects they experience.

Supriya Pathak and Ratna Pathak Shah tackle obesity stigma in new ad. ‘It’s not a joke’

The ad by Lilly India is opening the door to a weight loss conversation. It features links to research papers from the World Health Organisation and Columbia University.

Weight-loss drugs are changing. Here’s what to know about GLP-1s

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them out of reach for many. Pills, which will be cheaper, might change that.

Indian middle class is fed up with being paunchy and plump. Ozempic and Mounjaro are big hits

The instant success of weight loss drugs in India tells us how quickly the country is changing. And for once, the change is for the better.

‘Fat-shamers are now Ozempic-shamers’ — new book takes on India’s weight-loss obsession

The panel discussing Ambrish Mithal and Shivam Vij’s book on obesity and weight loss drugs included Minister of State Jitendra Singh, actor Sharmila Tagore, and HT Media chairperson Shobhana Bhartia.

India sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arena

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, as per estimates.

Ants & urine—how ancient Indian physician Sushruta discovered diabetes

In 'The Weight Loss Revolution', Dr Ambrish Mithal and Shivam Vij explain what GLP drugs are, who should use them, and how to manage the side-effects.

Mounjaro will shrink India’s appetite for packaged food, gyms, weight loss supplements

The pharmaceutical world’s latest blockbuster isn’t just changing waistlines but reshaping entire industries.

In Brazil’s São Paulo, armed gangs on the hunt for something more sought-after than gold—Ozempic

Desperation for ‘weight-loss’ drug that’s used to treat type-2 diabetes is real. Break-ins at pharmacies have also been reported in Michigan, US, and Santiago de Copostela, Spain. 

On Camera

Indian influencers reclaim desi aesthetics at Coachella—jhumkas, dupattas to mehendi

By mixing Indian maximalism with Western minimalism, desi influencers are using the hippie Met Gala to bring about a quiet revolution in festival dressing.

Recovery of energy flows will be ‘gradual rather than immediate’ as Hormuz re-opens post ceasefire

The reopening of the Strait of Hormuz eases supply fears, but controlled shipping, slow output recovery, and high costs may delay oil flow normalisation for months.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.